Influence of venezuelan equine encephalitis, influenza and mumps vaccine viral strains on morphological patterns and viability of human tumor cells in vitro

Journal of B.U.ON.

Volumn 8, Issue 1, 2003, Pages 39-43

  Rogozin, Evgeny A ^a   Urazova, L N ^b   Serebrov, V Yu ^a  

^a SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b CANCER RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Cell viability; Human tumour cells; Morphological changes; Vaccine; Virus

Indexed keywords

ENCEPHALITIS VACCINE; INFLUENZA VACCINE; MUMPS VACCINE;

ARTICLE; CANCER; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL CYCLE PHASE; CELL NUCLEUS; CELL STRAIN K 562; CELL TRANSFORMATION; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DYSTROPHY; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; INFLUENZA VIRUS; MITOSIS; MORPHOLOGICAL TRAIT; MUMPS VIRUS; TUMOR CELL LINE; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS STRAIN;

EID: 0038737912     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Yoshikawa T, Kokura S, Tainaka K et al. A novel cancer therapy based on oxygen radicals. Cancer Res 1995;55: 1617-1620.
2. Adams GE, Hasan NM, Joiner MC. Radiation, hypoxia and genetic stimulation: Implication for future therapies. Radiother Oncol 1997; 44: 101-109.
3. Moiseenko BM. Biotherapy of solid tumors. Oncol Problems 1998; 44: 120-126 (in russian).
4. Gupta M, Majumder UK, Roy MR, Mukhopadhyay DK. Inhibition of experimental murine tumors by a new compound isolated from mutated penicillium nigricans. Exper Oncol 1999; 21: 150-153.
5. Hersey P. Evaluation of vaccinia viral lysates as therapeutic vaccines in the treatment of melanoma. Ann NY Acad Sci 1993; 690: 167-177.
6. Sinkovics J, Horvath J. New developments in the virus therapy of cancer: A historical review. Intervirol 1993; 36: 193-214.
7. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-5757.
8. Brown JM, Giaccia AJ. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 1998; 58:1408-1416.
9. Urazova LN, Gromova AY, Perelmuter VM. Immunologic mechanisms in anti-tumor effect of vaccine strain of venezuelan equine encephalitis virus. Exper Oncol 1998; 20: 60-65 (in russian).
10. Rogozin EA, Urazova LN, Ilynskikh NN. Influence of venezuelan equine encephalitis virus on viability and the level of cytogenetic damages in Ehrlich's carcinoma cells in vitro. Exper Oncol 1999; 21: 70-72 (in russian).
11. Urazova LN, Rogozin EA, Ilyinskikh NN. Change in viability and cytogenetic parameters of ascitic Ehrlich's carcinoma under action of live vaccines of RNA-viruses in vitro. Bull Experim Biol Medicine 1999; (appendix 1): 107-109 (in russian).
12. Rogozin EA, Urazova LN, Vidjeva IG. Biotherapy of experimental tumors by viral vaccines of venezuelan equine encephalitis, mumps, and influenza, and estimation of their efficiency with the use of cytological parameters. Oncol Problems 2002; 48: 710-713 (in russian)
13. Krayevski NA, Smolyaninova AV, Sarkisova DS (eds). Manual of Pathologoanatomic Diagnosis of Human Tumors (Vol 1) Moskow, 1993 (in russian).
14. Marchenko IM, Podoplyokin VD, Solyanik RG, Fyodorov YV. Some characteristics of attenuated versions of venezuelan encephalomyelitis virus in horses. Arboviruses: Proc XVI Scientific Session of Poliomyelitis and Viral Encephalitis Institute. Moscow, 1969;2:237-247 (in russian).
15. Goldberg YD, Dygai AM, Shakhov VP. Methods of Tissue Culture in Haematology. Tomsk: TGV Publ, 1992 (in russian).
16. Schlesinger MJ. Replication of togaviruses. In: Fields BN, Knipe DM (eds): Fundamental Virology (Vol 2) Raven Press Ltd, New York, 1989 pp 343-365.